The offering, which is being led by Clarus Securities, is for 3,173,936 common shares at a price of $3.15 per share, which would bring $9,997,898.40 in gross proceeds. Aurora Spine also paid a cash commission to Clarus of 5.5 percent of the gross proceeds.
Proceeds will go toward manufacturing, sales and marketing of the ZIP device.
More Articles on Devices:
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement
CMS to Cover Image-Guided Lumbar Decompression With Coverage Evidence Development
NuVasive Releases Preliminary Financials, Expects $683M in 2013 Revenue
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
